Baptist Medical Center South in Jacksonville, Fla., opened its new ambulatory surgery center in the hospital's new 100,000 square-foot, five-story medical building, according to a report in Financial News & Daily Record.
The Latest
NovaMed, an operator of ambulatory surgery centers in partnership with physicians, has announced its financial results for the third quarter ending Sept. 30. The company posted total net revenue growth of 8 percent to nearly $38.768 million, up from $36.05…
Raleigh, N.C.-based WakeMed, a 870-bed, non-profit hospital and healthcare system, is exploring a potential partnership with Surgical Care Affiliates, which manages ASCs throughout the country, according to a report in The News & Observer.
The U.S. Attorney for Massachusetts has indicted Stryker Biotech and four of its top managers, charging them with conducting fraudulent marketing for Stryker's OP-1 and Calstrux bone growth products, according to a release by the U.S. Attorney's Office.
Jon Vick, president of ASCs, Inc., an ASC consulting firm, shares his thoughts on how health reform legislation will impact ASCs and how individual centers can best deal with changes brought on by this reform.
WellPoint, which operates as UniCare in Illinois and Texas, said that it will end service in both states, leaving 580,000 members to find new health coverage, according to a report by the Chicago Tribune.
Ridgeview Medical Center broke ground on Two Twelve Medical Center in Chaska, Minn., which will feature clinics, urgent care and outpatient surgery services, among other healthcare services, according to a release from Ridgeview Medical Center.
Current healthcare reform legislation includes provisions that would increase efforts to investigate Medicare and Medicaid fraud, according to a report by the Wall Street Journal.
GENASCIS, a leading revenue cycle management and business intelligence resource for ASCs, has launched a new microsite, CompareMyASC.com, to provide ASCs a free comparative analysis of their revenue cycle performance, according to a GENASCIS news release.
U.S. Senate leadership reportedly has reduced the proposed levy on medical device makers in the health reform bill from $40 billion to between $15 billion and $20 billion over 10 years, according to a report by the Wall Street Journal.